Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2266
Full Text
Open PDFAbstract
Available in full text
Date
January 31, 2017
Authors
Publisher
American Association for Cancer Research (AACR)